These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37833878)

  • 1. Effect of the Cannabinoid Agonist WIN 55,212-2 on Neuropathic and Visceral Pain Induced by a Non-Diarrheagenic Dose of the Antitumoral Drug 5-Fluorouracil in the Rat.
    Vera G; López-Gómez L; Girón R; Martín-Fontelles MI; Nurgali K; Abalo R; Uranga JA
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat.
    Abalo R; Uranga JA; Pérez-García I; de Andrés R; Girón R; Vera G; López-Pérez AE; Martín-Fontelles MI
    Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 27686064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats.
    Pascual D; Goicoechea C; Suardíaz M; Martín MI
    Pain; 2005 Nov; 118(1-2):23-34. PubMed ID: 16213089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy.
    Vera G; Cabezos PA; Martín MI; Abalo R
    Pharmacol Biochem Behav; 2013 Apr; 105():205-12. PubMed ID: 23454533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat.
    Vera G; Chiarlone A; Cabezos PA; Pascual D; Martín MI; Abalo R
    Life Sci; 2007 Jul; 81(6):468-79. PubMed ID: 17673260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.
    Ahmed MM; Rajpal S; Sweeney C; Gerovac TA; Allcock B; McChesney S; Patel AU; Tilghman JI; Miranpuri GS; Resnick DK
    Spine J; 2010 Dec; 10(12):1049-54. PubMed ID: 20920894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes.
    Vera G; López-Miranda V; Herradón E; Martín MI; Abalo R
    Pharmacol Biochem Behav; 2012 Aug; 102(2):335-43. PubMed ID: 22609797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.
    Burgos E; Gómez-Nicola D; Pascual D; Martín MI; Nieto-Sampedro M; Goicoechea C
    Eur J Pharmacol; 2012 May; 682(1-3):62-72. PubMed ID: 22374260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats.
    Ulugol A; Karadag HC; Ipci Y; Tamer M; Dokmeci I
    Neurosci Lett; 2004 Nov; 371(2-3):167-70. PubMed ID: 15519750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat.
    Abalo R; Cabezos PA; Vera G; López-Pérez AE; Martín MI
    Neurogastroenterol Motil; 2013 May; 25(5):373-82, e292. PubMed ID: 23594243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
    Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
    Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.
    Hama A; Sagen J
    Brain Res; 2011 Sep; 1412():44-54. PubMed ID: 21813113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms.
    Potenzieri C; Harding-Rose C; Simone DA
    Brain Res; 2008 Jun; 1215():69-75. PubMed ID: 18486111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
    Johanek LM; Simone DA
    Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of styrene maleic acid WIN55,212-2 micelles on neuropathic pain in a rat model.
    Linsell O; Brownjohn PW; Nehoff H; Greish K; Ashton JC
    J Drug Target; 2015 May; 23(4):353-9. PubMed ID: 25541465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.
    Liang YC; Huang CC; Hsu KS
    Neuropharmacology; 2007 Jul; 53(1):169-77. PubMed ID: 17572451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect.
    Doğrul A; Gül H; Yildiz O; Bilgin F; Güzeldemir ME
    Neurosci Lett; 2004 Sep; 368(1):82-6. PubMed ID: 15342139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain.
    Hama A; Sagen J
    J Rehabil Res Dev; 2009; 46(1):135-43. PubMed ID: 19533526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms.
    Johanek LM; Heitmiller DR; Turner M; Nader N; Hodges J; Simone DA
    Pain; 2001 Sep; 93(3):303-315. PubMed ID: 11514089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain.
    Costa B; Colleoni M; Conti S; Trovato AE; Bianchi M; Sotgiu ML; Giagnoni G
    Br J Pharmacol; 2004 Jan; 141(1):4-8. PubMed ID: 14662732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.